PDS Biotechnology Corporation is a leading biotech company based in Florham Park, NJ, dedicated to transforming cancer treatment and addressing infectious diseases through the power of T cells. With their proprietary cationic, lipid-based nanoparticle platform technologies, they have successfully designed immunotherapies that activate T cells to execute targeted attacks on various cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, and more.
By harnessing the body's own immune system, PDS Biotech aims to create a new generation of targeted cancer immunotherapies and infectious disease vaccines, offering promising solutions for patients with limited treatment options. Their powerful T cell activating platforms have the potential to significantly improve treatment outcomes and revolutionize the field of immunotherapy.
Generated from the website